Insufficient scRNA-seq data for expression of SERPINA12 at single-cell level.
Insufficient scRNA-seq data for expression of SERPINA12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 56% | 69.17 | 127 / 226 | 39% | 4.45 | 158 / 406 |
skin | 72% | 15963.26 | 1308 / 1809 | 14% | 1.57 | 66 / 472 |
breast | 14% | 8.56 | 62 / 459 | 28% | 1.26 | 315 / 1118 |
ovary | 17% | 9.78 | 30 / 180 | 4% | 0.12 | 18 / 430 |
esophagus | 2% | 1.24 | 31 / 1445 | 4% | 0.25 | 7 / 183 |
lung | 3% | 3.65 | 17 / 578 | 3% | 0.08 | 34 / 1155 |
adrenal gland | 2% | 0.73 | 4 / 258 | 4% | 0.37 | 9 / 230 |
thymus | 3% | 1.52 | 18 / 653 | 2% | 0.04 | 11 / 605 |
kidney | 0% | 0 | 0 / 89 | 5% | 0.11 | 41 / 901 |
uterus | 3% | 3.66 | 5 / 170 | 2% | 0.08 | 7 / 459 |
adipose | 4% | 14.68 | 43 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
stomach | 2% | 0.93 | 7 / 359 | 1% | 0.03 | 4 / 286 |
muscle | 3% | 6.18 | 25 / 803 | 0% | 0 | 0 / 0 |
heart | 3% | 1.19 | 25 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 1.39 | 26 / 929 | 0% | 0 | 0 / 0 |
intestine | 2% | 1.21 | 21 / 966 | 0% | 0.01 | 2 / 527 |
blood vessel | 2% | 11.86 | 31 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
pancreas | 1% | 1.01 | 3 / 328 | 1% | 0.04 | 2 / 178 |
brain | 2% | 1.14 | 43 / 2642 | 0% | 0.00 | 2 / 705 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.04 | 5 / 504 |
spleen | 1% | 0.27 | 2 / 241 | 0% | 0 | 0 / 0 |
prostate | 0% | 0.15 | 1 / 245 | 0% | 0 | 0 / 502 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090181 | Biological process | regulation of cholesterol metabolic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0051055 | Biological process | negative regulation of lipid biosynthetic process |
GO_0090207 | Biological process | regulation of triglyceride metabolic process |
GO_0008610 | Biological process | lipid biosynthetic process |
GO_0006094 | Biological process | gluconeogenesis |
GO_0045721 | Biological process | negative regulation of gluconeogenesis |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0046628 | Biological process | positive regulation of insulin receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0140678 | Molecular function | molecular function inhibitor activity |
Gene name | SERPINA12 |
Protein name | Serpin A12 (OL-64) (Visceral adipose tissue-derived serine protease inhibitor) (Vaspin) (Visceral adipose-specific serpin) |
Synonyms | |
Description | FUNCTION: Adipokine that modulates insulin action by specifically inhibiting its target protease KLK7 in white adipose tissues. . |
Accessions | ENST00000677451.1 Q8IW75 ENST00000341228.2 ENST00000556881.5 |